Clinical trial
Cross-Sectional Study of the Prevalence of TGFBI Corneal Dystrophies
NCT02746055 is registered in ClinicalTrials.gov with Avellino Labs USA, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cross-Sectional Study of the Prevalence of TGFBI Corneal Dystrophies
- Lead sponsor
- Avellino Labs USA, Inc.
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 30, 2016
- Completion date
- April 30, 2017
- Enrollment
- 20,000 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
corneal dystrophy